Lagan Seamus 4
4 · Rennova Health, Inc. · Filed Jul 25, 2018
Insider Transaction Report
Form 4
Lagan Seamus
DirectorCEO and President
Transactions
- Award
Series J Convertible Preferred Stock
2018-07-23$1.00/sh+250,000$250,000→ 250,000 total(indirect: By LLC)Exercise: $0.00From: 2018-07-23→ Common Stock (147,058,824 underlying)
Footnotes (5)
- [F1]As of July 23, 2018. The conversion price equals the average closing price of the common stock for the 10 trading days prior to the conversion date.
- [F2]Based on the conversion price as of July 23, 2018.
- [F3]Each share of the Series J Convertible Preferred Stock has the number of votes equal to the number of shares of common stock into which it is convertible, except that, for certain specified matters, through September 30, 2018 only each share has 12,000 votes.
- [F4]Alcimede LLC received the shares in exchange for the cancellation of outstanding debt.
- [F5]The Series J Preferred Stock will remain outstanding until either converted or redeemed by the Company.